|
|
|
Fiscal Period: April
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Capitalization1 |
107 576 | 114 856 | 133 078 | 149 794 | - | - |
| Entreprise Value (EV)1 |
122 106 | 130 332 | 153 735 | 169 354 | 166 398 | 161 241 |
| P/E ratio |
35,0x | 25,1x | 28,1x | 38,4x | 24,8x | 21,1x |
| Yield |
2,32% | 2,34% | 2,34% | 2,03% | 2,13% | 2,25% |
| Capitalization / Revenue |
3,59x | 3,76x | 4,60x | 5,14x | 4,65x | 4,35x |
| EV / Revenue |
4,08x | 4,27x | 5,32x | 5,81x | 5,17x | 4,68x |
| EV / EBITDA |
13,3x | 13,3x | 18,1x | 21,7x | 16,0x | 14,0x |
| Price to Book |
2,12x | 2,30x | 2,62x | 2,95x | 2,81x | 2,62x |
| Nbr of stocks (in thousands) |
1 355 373 | 1 341 151 | 1 340 166 | 1 344 409 | - | - |
| Reference price (USD) |
79,4 | 85,6 | 99,3 | 111 | 111 | 111 |
| Last update |
05/24/2018 | 05/23/2019 | 05/21/2020 | 10/20/2020 | 10/20/2020 | 10/20/2020 |
|
1 USD in Million Estimates
|
|
| Income Statement Evolution | |
|
|
|
| Annual Income Statement Data |
|
|
Fiscal Period: April
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Net sales1 |
29 953 | 30 557 | 28 913 | 29 168 | 32 216 | 34 455 |
| EBITDA1 |
9 173 | 9 767 | 8 472 | 7 795 | 10 413 | 11 483 |
| Operating profit (EBIT)1 |
8 352 | 8 872 | 7 565 | 6 691 | 9 387 | 10 286 |
| Operating Margin |
27,9% | 29,0% | 26,2% | 22,9% | 29,1% | 29,9% |
| Pre-Tax Profit (EBT)1 |
5 675 | 5 197 | 4 055 | 4 673 | 6 978 | 8 213 |
| Net income1 |
3 104 | 4 631 | 4 789 | 3 958 | 6 026 | 7 062 |
| Net margin |
10,4% | 15,2% | 16,6% | 13,6% | 18,7% | 20,5% |
| EPS2 |
2,27 | 3,41 | 3,54 | 2,90 | 4,49 | 5,28 |
| Dividend per Share2 |
1,84 | 2,00 | 2,32 | 2,26 | 2,37 | 2,51 |
| Last update |
05/24/2018 | 05/23/2019 | 05/21/2020 | 10/20/2020 | 10/20/2020 | 10/20/2020 |
|
1 USD in Million 2 USD Estimates
|
|
|
|
|
Fiscal Period: April
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Net Debt1 |
14 530 | 15 476 | 20 657 | 19 560 | 16 604 | 11 447 |
| Net Cash position1 |
- | - | - | - | - | - |
| Leverage (Debt / EBITDA) |
1,58x | 1,58x | 2,44x | 2,51x | 1,59x | 1,00x |
| Free Cash Flow1 |
4 700 | 5 873 | 6 021 | 3 596 | 6 582 | 7 164 |
| ROE (Net Profit / Equities) |
12,9% | 14,1% | 12,3% | 10,7% | 15,6% | 16,4% |
| Shareholders' equity1 |
23 988 | 32 928 | 38 903 | 36 833 | 38 561 | 43 174 |
| ROA (Net Profit / Asset) |
6,83% | 7,83% | 6,88% | 5,49% | 5,59% | 9,10% |
| Assets1 |
45 455 | 59 149 | 69 598 | 72 130 | 107 786 | 77 599 |
| Book Value Per Share2 |
37,4 | 37,2 | 37,8 | 37,7 | 39,6 | 42,5 |
| Cash Flow per Share2 |
3,42 | 5,16 | 5,35 | 2,90 | 3,09 | - |
| Capex1 |
1 068 | 1 134 | 1 213 | 1 293 | 1 331 | 1 415 |
| Capex / Sales |
3,57% | 3,71% | 4,20% | 4,43% | 4,13% | 4,11% |
| Last update |
05/24/2018 | 05/23/2019 | 05/21/2020 | 10/20/2020 | 10/20/2020 | 10/20/2020 |
|
1 USD in Million 2 USD Estimates
|
|
|
|
|
|
Financial data source
© 2020 S&P Global Market Intelligence
|
|
|
Investors eye discounted U.S. healthcare sector as Biden's lead in polls grows |
Capitalization (USD) 149 794 032 507 Net sales (USD) 28 913 000 000 Number of employees 90 000 Sales / Employee (USD) 321 256 Free-Float capitalization (USD) 149 695 799 739 Avg. Exchange 20 sessions (USD) 505 380 440 Average Daily Capital Traded 0,34%
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Evolution Valeur d'Entreprise / EBITDA
|
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
